Abstract
This Practice Point commentary discusses the findings of a prospective study by Kuypers et al. that was designed to determine the best clinical diagnostic tool for identifying patients at risk of developing post-transplantation diabetes mellitus (PTDM) following renal transplantation. Fasting plasma glucose (FPG) levels on the day of transplantation and FPG levels and an oral glucose tolerance test (OGTT) at 5 days after transplantation were evaluated in de novo renal transplant recipients. The predictive values of these tests were assessed alongside other known risk factors for PTDM. A normal (vs diabetic) OGTT on day 5 was associated with a significantly reduced risk for PTDM (odds ratio 0.03; P = 0.0002). A similar reduction in the risk of PTDM was conferred by normal FPG levels on day 5 (odds ratio 0.06; P <0.0001). While the OGTT or FPG test at 5 days after transplantation might prove to be useful predictive diagnostic tools for the development of PTDM, studies that incorporate baseline evaluation of pre-existing glucose metabolic disorders are needed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Pham PT et al. (2007) New onset diabetes mellitus after solid organ transplantation. Endocrinol Metab Clin North Am 36: 873–890
Kuypers DR et al. (2008) Early clinical assessment of glucose metabolism in renal allograft recipients: diagnosis and prediction of post-transplant diabetes mellitus (PTDM). Nephrol Dial Transplant 23: 2033–2042
Pham PT et al. (2007) The medical management of the renal transplant recipient. In Comprehensive Clinical Nephrology, edn 3, 1085–1101 (Eds Johnson RJ. et al.) Philadelphia: Mosby
Baid S et al. (2001) Posttransplant diabetes in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation 72: 1066–1072
Nathan DM et al. (2007) Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 30: 753–759
Sharif A et al. (2006) The use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: an underdiagnosed phenomenon. Transplantation 82: 1667–1672
Valderhaug TG et al. (2007) Reduced incidence of new-onset postransplantation diabetes mellitus during the last decade. Transplantation 84: 1125–1130
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Pham, PT., Pham, PC. Assessing the risk of post-transplantation diabetes mellitus with an oral glucose tolerance test. Nat Rev Nephrol 4, 600–601 (2008). https://doi.org/10.1038/ncpneph0928
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpneph0928